Share price

Upcoming events
Stroke 10 to

Drug Delivery & Formulation Summit

Maritim proArte Hotel
10117 Berlin

Stroke 10 to

CPHI North America 2023

1101 Arch St
Philadelphia, 19107
United States

Stroke 10 to

CPhI Japan 2023

3 Chome-11-1 Ariake, Koto City


EUROAPI profile


With an industrial footprint all located in Europe and thanks to a wide range of advanced technologies, EUROAPI develops, manufactures, markets and distributes APIs and intermediates used in the formulation of medicines for human and veterinary use, both from originators and generics, through its API Solutions business and CDMO activities. 

Through these activities, EUROAPI offers its customers a range of high value-added products and services to meet their commercial and regulatory needs. These customers include most of the major pharmaceutical companies, generic drug and animal health product manufacturers, consumer health and nutrition products companies, biotechnology companies and distribution companies.

EUROAPI’s strategy to further grow is focused on clear business and operational levers. We aim at accelerating our CDMO activities, expanding our differentiated presence with a particular emphasis on highly potent and complex APIs as well as tides, developing our product portfolio and realizing standalone efficiencies.

Key figures

  • 150

    years of experience in the API market

  • €902 m

    of restated revenue in 2021

  • ~200


  • ~530

    customers in 80+ countries

  • ~330

    employees in its R&D team dedicated to industrial process development

  • ~3,350